InvestorsHub Logo
icon url

Rawnoc

07/19/13 8:19 AM

#10876 RE: mp15shoot #10874

Why is Amarin Management silent?

That is the better question.



Because they know his snake oil scam doesn't have a prayer.
icon url

KCSVEN

07/19/13 8:20 AM

#10877 RE: mp15shoot #10874

They responded via FAQ on the website.

The study did not use Vassepa and has nothing to do with Vascepa so it would be hard for them to get giant media coverage like the initial report.
They cannot come out and say anything definitive on a study they had no involvement in so not sure what people think they would say that would get any type of play that would be factual and be picke dup by mass media.

In 2011 when the same people said DHA causes cancer, the same thing happenned and GSK, as they are also doing now, ignored them and let the science community debunk.

GSK is more in the target hairs of this false report and they are doing the same as AMRN, actually less as AMRN, at least AMRN addressed on their website. GSK is doing what you are supposed to do, ignoring it, if you spend time attacking it all you do is give it some legitimacy.
icon url

jessellivermore

07/19/13 8:47 AM

#10879 RE: mp15shoot #10874

"Why is Amarin Management silent?"

Management is silent because the FDA has a defacto gag order on them.
The FDA has informed AMRN that they are not to make any claims for Vascepa other than the MARINE indication for trigs >500mg/dl.

I find this amazing since they did successfully complete an FDA SPA for the ANCHOR indication..We are told the FDA is in place to protect us against false claims...guess they do not put much stock in their own requirements, or is there something else going on we do not know about.

":>) JL